Inflammatory Bowel Diseases
"Inflammatory Bowel Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Descriptor ID |
D015212
|
| MeSH Number(s) |
C06.405.205.731 C06.405.469.432
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammatory Bowel Diseases".
Below are MeSH descriptors whose meaning is more specific than "Inflammatory Bowel Diseases".
This graph shows the total number of publications written about "Inflammatory Bowel Diseases" by people in this website by year, and whether "Inflammatory Bowel Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammatory Bowel Diseases" by people in Profiles.
-
Wynne J, Kozuch P. Medical marijuana for inflammatory bowel disease: the highs and lows. Scand J Gastroenterol. 2022 Feb; 57(2):197-205.
-
Peters LA, Perrigoue J, Mortha A, Iuga A, Song WM, Neiman EM, Llewellyn SR, Di Narzo A, Kidd BA, Telesco SE, Zhao Y, Stojmirovic A, Sendecki J, Shameer K, Miotto R, Losic B, Shah H, Lee E, Wang M, Faith JJ, Kasarskis A, Brodmerkel C, Curran M, Das A, Friedman JR, Fukui Y, Humphrey MB, Iritani BM, Sibinga N, Tarrant TK, Argmann C, Hao K, Roussos P, Zhu J, Zhang B, Dobrin R, Mayer LF, Schadt EE. A functional genomics predictive network model identifies regulators of inflammatory bowel disease. Nat Genet. 2017 Oct; 49(10):1437-1449.
-
Shivashankar R, Lewis JD. The Role of Diet in Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2017 May; 19(5):22.
-
Serebrennikova OB, Tsatsanis C, Mao C, Gounaris E, Ren W, Siracusa LD, Eliopoulos AG, Khazaie K, Tsichlis PN. Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation. Proc Natl Acad Sci U S A. 2012 May 1; 109(18):E1082-91.
-
Forsberg F. Science to practice: Can contrast-enhanced US of targeted microbubbles be used to monitor and quantify inflammation in patients with inflammatory bowel disease? Radiology. 2012 Jan; 262(1):1-2.
-
Toll AD, Boman BM, Palazzo JP. Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase. Hum Pathol. 2012 Feb; 43(2):238-42.
-
Moleski SM, Choudhary C. Special considerations for women with IBD. Gastroenterol Clin North Am. 2011 Jun; 40(2):387-98, viii-ix.
-
Szigethy E, McLafferty L, Goyal A. Inflammatory bowel disease. Child Adolesc Psychiatr Clin N Am. 2010 Apr; 19(2):301-18, ix.
-
Kozuch PL, Hanauer SB. Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol. 2008 Jan 21; 14(3):354-77.
-
Kozuch PL, Hanauer SB. General principles and pharmacology of biologics in inflammatory bowel disease. Gastroenterol Clin North Am. 2006 Dec; 35(4):757-73.